Patents by Inventor Roger Geiger

Roger Geiger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNERGISTIC COMBINATIONS OF ARGININE-PRODUCING BACTERIA AND/OR AMMONIA-CONSUMING BACTERIA AND CHECKPOINT INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20220226397
    Abstract: Disclosed herein are synergistic compositions and methods using arginine-producing bacteria and/or ammonia-consuming bacteria in combination with a checkpoint inhibitor for use in treating cancer.
    Type: Application
    Filed: May 13, 2020
    Publication date: July 21, 2022
    Inventors: Jose M. Lora, Roger Geiger
  • Arginine and its use as a T cell modulator
    Patent number: 11167015
    Abstract: The present invention provides novel uses and methods for T cell based immunotherapies. Specifically, the invention relates to novel ligands, targets and nucleic acids and vectors encoding said targets that are useful for modulating T cell responses.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: November 9, 2021
    Assignee: INSTITUTE FOR RESEARCH IN BIOMEDICINE
    Inventors: Roger Geiger, Antonio Lanzavecchia, Federica Sallusto
  • Arginine And Its Use As A T Cell Modulator
    Publication number: 20190307856
    Abstract: The present invention provides novel uses and methods for T cell based immunotherapies. Specifically, the invention relates to novel ligands, targets and nucleic acids and vectors encoding said targets that are useful for modulating T cell responses.
    Type: Application
    Filed: October 12, 2017
    Publication date: October 10, 2019
    Inventors: Roger GEIGER, Antonio LANZAVECCHIA, Federica SALLUSTO
  • NOVEL VACCINES IN PREVENTION AND TREATMENT OF MALARIA
    Publication number: 20180186897
    Abstract: The present invention provides a pharmaceutical composition, for example a vaccine, which comprises a RIFIN, which is able to bind to a mutated LAIR-1 fragment, which broadly binds to erythrocytes infected with Plasmodium falciparum. Such a RIFIN may be useful in the prevention and/or treatment of malaria.
    Type: Application
    Filed: June 24, 2016
    Publication date: July 5, 2018
    Inventors: Antonio Lanzavecchia, Roger Geiger, Luca Piccoli